Fig. 2From: Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathwayRegulation of MDR1, MRP1 and BCRP expression. Western blot analysis MDR1, MRP1 and BCRP expression of MG-63 cells untreated or treated with celecoxib (50, 100 µmol/l), cisplatin (10 µg/ml), and the combination for 48 h. Significant down-regulation of MDR1, MRP1 and BCRP expression was observed in cells treated with cisplatinBack to article page